Erlotinib coupons
Erlotinib

Erlotinib Coupons & Discount Card - Compare Prices Near You

generic Tarceva

Erlotinib, known by the brand name Tarceva, is an oral medication prescribed for treating certain types of lung and pancreatic cancers. Specifically, it is used for metastatic non-small cell lung cancer (NSCLC) in some adults and for advanced, unresectable, or metastatic pancreatic cancer, often in combination with another drug called gemcitabine (Gemzar). Erlotinib functions as a targeted anticancer treatment by inhibiting a specific protein called the epidermal growth factor receptor (EGFR), which is present in higher amounts on cancer cells compared to healthy cells. By blocking EGFR, erlotinib helps to slow or stop the growth and spread of cancer cells. Patients should be aware that while erlotinib is an effective treatment option, it may cause side effects such as skin rashes and diarrhea. It is important to consult with healthcare professionals before starting treatment to ensure it is safe and appropriate for individual health needs.
Our coupons are free to use. Before paying, show the pharmacist your Erlotinib savings card to get your free discount. Use our filters below to edit the prescription box to match your needs. The Erlotinib prices will update based on your prescription needs. Above our Erlotinib coupons, you can change your location to see pharmacy prices and costs in other areas. We're here to help you buy Erlotinib at the lowest price with our prescription discount card.

My prescription

Edit

100MG, Erlotinib (30 Tablets)

Select pharmacy

Pharmacy logo

Walgreens

$2212.71

COUPON PRICE
Pharmacy logo

Rite Aid

$5963.68

COUPON PRICE

Erlotinib savings card

Show this card to your pharmacist
Pharmacy logo

Walgreens

$2212.71

BIN

ID

PCN

GRP

019876

LH88A0B883

CHIPPO

LHX

Powered by

This card is not insurance

Erlotinib dosage forms

The average cost for 30 Tablets of Erlotinib (generic Tarceva) at 25MG is $804.33 with a free coupon. This is 9.44% off the average retail price of $8518.2
DosageQuantityPrice fromPer unit
25MG30 Tablets$804.33$26.81
100MG30 Tablets$2212.71$73.76
150MG30 Tablets$2503$83.43

Erlotinib Warnings

The following information outlines important safety warnings for the use of erlotinib (Tarceva). It is crucial to understand these risks and consult your healthcare provider if you have any concerns or experience any symptoms described below.

  • Severe Lung or Breathing Problems: In rare cases, erlotinib has been associated with a condition known as interstitial lung disease (ILD), which causes scarring of the lungs. Symptoms may appear from 5 days to 9 months after starting treatment. If you experience new or worsening breathing difficulties, chest pain, a dry cough, or fever, contact your healthcare provider immediately. Treatment may need to be paused or stopped to investigate these symptoms.

  • Kidney or Liver Damage: This medication can occasionally lead to serious kidney issues. Regular laboratory tests will be conducted by your healthcare provider to monitor kidney function. If you notice changes in urination frequency or blood in your urine, notify your provider promptly. The risk is higher if you have a history of liver problems or are dehydrated.

  • Gastrointestinal Perforation: Although extremely rare, there is a risk of tears in the stomach, intestines, or bowel, which can be life-threatening. This risk increases if you are also taking medications that affect blood vessel formation, corticosteroids, NSAIDs, or taxane chemotherapy. Seek immediate medical attention if you experience severe abdominal pain, fever, nausea, or vomiting.

  • Severe Skin Problems: Erlotinib may cause skin issues such as pus-filled blisters, dry or cracking skin, nail changes, and excessive hair growth. Serious skin reactions or infections, though rare, can be life-threatening. Report any painful blisters, skin wounds, or peeling to your provider immediately, as these require urgent medical care.

  • Stroke: There is a rare risk of blood clots in the brain, potentially leading to a stroke. Call emergency services if you experience severe headaches, sudden confusion, weakness on one side of your body, or difficulties with speech or movement.

  • Eye Problems: Potential effects include reduced tear production, dry eyes, abnormal eyelash growth, and eye inflammation. Rarely, these may lead to severe complications. Report any eye pain or vision changes to your healthcare provider right away.

  • Serious Bleeding Risk with Warfarin: Concurrent use of warfarin (Coumadin) and erlotinib increases the risk of bleeding. Regular blood tests will be conducted to ensure safe dosing. Seek immediate medical help if you observe signs of bleeding, such as blood in your urine or stool, or if bleeding from a wound does not stop.

  • Risk to Unborn Baby: Animal studies suggest that erlotinib may harm an unborn baby or increase the risk of miscarriage. Women who can become pregnant should use effective contraception during treatment and for one month after the last dose. Inform your healthcare provider immediately if you become pregnant while taking this medication.

Please ensure you discuss any concerns or symptoms with your healthcare provider to ensure safe and effective use of erlotinib (Tarceva).

Erlotinib Side Effects

Common side effects:

  • rash
  • diarrhea
  • loss of appetite
  • extreme tiredness
  • cough
  • difficulty breathing
  • nausea
  • infection
  • dry skin
  • back pain
  • chest pain
  • itching
  • changes in your nails
  • joint or muscle pain
  • eye inflammation

Less common but important to monitor:

  • severe rash

Serious side effects:

  • symptoms of a stroke (severe headaches, visual changes, sudden confusion)
  • serious lung problems (extreme tiredness, dry cough)
  • kidney issues (blood in the urine, painful urination)
  • liver damage (dark urine, stomach pain, yellowing of the eyes or skin, loss of appetite)
  • damage to the gut (intense stomach pain, fever, chills)
  • severe skin reactions (painful blisters or sores)
  • serious bleeding (unexplained bruising, throwing up blood)
  • very serious allergic reaction (extensive rash, swelling of the face, tongue, or throat, severe dizziness, trouble breathing)

Erlotinib Interactions

Interactions with high risk of serious adverse effects and should be avoided:

  • omeprazole
  • warfarin
  • dabigatran
  • Aspirin
  • Acenocoumarol
  • Amiodarone
  • Boceprevir
  • Indinavir
  • Lopinavir
  • Nelfinavir
  • Ritonavir
  • Saquinavir
  • Telaprevir
  • Itraconazole
  • Ketoconazole
  • Posaconazole
  • Voriconazole
  • Clarithromycin
  • Telithromycin
  • Carbamazepine
  • Ciprofloxacin
  • Enzalutamide
  • Lumacaftor
  • Mitotane
  • Phenobarbital
  • Phenytoin
  • Rifabutin
  • Rifampin
  • Rifapentine
  • St John's Wort

Interactions with moderate risk that may require dose adjustment, closer monitoring, or timing changes:

  • clopidogrel
  • ibuprofen
  • naproxen
  • Cimetidine
  • Famotidine
  • Ranitidine
Erlotinib FAQs
Is erlotinib a chemotherapy drug?

Erlotinib is not a traditional chemotherapy drug. It is classified as a targeted therapy, specifically a tyrosine kinase inhibitor, used to treat certain types of cancer by targeting specific proteins involved in cancer cell growth.

The most common side effect of erlotinib is a skin rash.

Yes, erlotinib is an EGFR (epidermal growth factor receptor) inhibitor.

Erlotinib targets the epidermal growth factor receptor (EGFR) tyrosine kinase. It is used to inhibit the activity of this receptor, which is involved in the growth and spread of cancer cells.

EGFR inhibitors are a class of drugs that target the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. Some common EGFR inhibitors include erlotinib, gefitinib, afatinib, osimertinib, and cetuximab. These medications are often used in the treatment of certain types of cancers, such as non-small cell lung cancer and colorectal cancer.